March 14, 2018: Students, faculty and staff in solidarity with Florida shooting victims and all who have suffered from gun violence

Faculty Positions in Infectious Disease Research

The Public Health Research Institute (PHRI; www.phri.org) of New Jersey Medical School, Rutgers Biomedical and Health Sciences, located in Newark, New Jersey, is recruiting two faculty members at the intermediate or senior levels. PHRI is a leading infectious disease research center that emphasizes basic and translational sciences. Candidates must have a Ph.D. and/or an M.D. and a funded research program addressing critical questions in fungal, bacterial, or viral biology and/or host responses. Concurrent active clinical practice will also be highly regarded. Preference will be given to programs focused on respiratory infections. PHRI is housed in a state of the art research facility that has extensive core services, including a nationally designated BSL3 laboratory and animal facilities and an X-ray facility for structural studies. PHRI offers a robust and highly collegial research environment, generous start-up funds, and a comprehensive benefits package. Candidates should submit a curriculum vitae, a statement of research interests and accomplishments, and a list of at least three references.

Any questions or applications should be sent to: Dr. Barry Kreiswirth, Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, 225 Warren Street, Newark, NJ 07103. Telephone: (973) 854-3240. Fax: (973) 854-3101. Email: kreiswba@njms.rutgers.edu

Rutgers, the State University of New Jersey, is an Equal Opportunity/Affirmative Action employer, and is compliant with the Americans with Disabilities Act (ADA). For more information, please visit www.recruitment.rutgers.edu. Women and minorities are encouraged to apply.

To download a PDF copy of the recruitment advertisement, select PDF Document.

Drs. Liang Chen and Barry Kreiswirth participated in a study that shows the potential of an antibody approach to treat multidrug-resistant Klebsiella pneumoniae. Visit www.niaid.nih.gov to read the NIH press release and follow this link to download a PDF copy of the publication describing their work.

03.06.18

Drs. Marras, Kramer, Tyagi and Vargas-Gold were awarded US Patent 9,909,159 for their invention of a novel PCR method, utilizing so-called "SuperSelective Primers", which is highly specific and sensitive and allows the detection and identification of rare mutant sequences in a background of abundant wild-type sequences, even if the difference between the sequences is a single nucleotide polymorphism.

01.30.18

A Postdoctoral position is available in the laboratory of Dr. Selvakumar Subbian. Visit Employment Opportunities for details.

01.26.18

Dr. David Perlin, executive director of PHRI, was among a select group of fellows elected into the American Academy of Microbiology. For details, please visit: www.asm.org.